Thu, August 20, 2020
Wed, August 19, 2020
Tue, August 18, 2020

Marc Goodman Maintained (BIIB) at Buy with Decreased Target to $342 on, Aug 19th, 2020

Marc Goodman of SVB Leerink, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $350 to $342 on, Aug 19th, 2020.

Marc has made no other calls on BIIB in the last 4 months.



There are 11 other peers that have a rating on BIIB. Out of the 11 peers that are also analyzing BIIB, 5 agree with Marc's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $273 on, Monday, June 22nd, 2020
  • Carter Gould of "Barclays" Downgraded from Buy to Hold and Decreased Target to $280 on, Monday, June 22nd, 2020
  • Aaron Gal of "Bernstein" Downgraded from Buy to Hold and Decreased Target to $297 on, Tuesday, June 9th, 2020
  • Alethia Young of "Cantor Fitzgerald" Reiterated at Hold with Decreased Target to $308 on, Friday, May 1st, 2020
  • Evan Seigerman of "Credit Suisse" Maintained at Hold with Decreased Target to $310 on, Thursday, April 23rd, 2020


These are the ratings of the 6 analyists that currently disagree with Marc


  • Matthew Harrison of "Morgan Stanley" Upgraded from Sell to Buy and Increased Target to $357 on, Monday, July 27th, 2020
  • Brian Skorney of "Baird" Maintained at Sell with Decreased Target to $228 on, Friday, June 19th, 2020
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $350 on, Friday, April 24th, 2020
  • Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $365 on, Thursday, April 23rd, 2020
  • Robyn Karnauskas of "SunTrust Robinson Humphrey" Maintained at Strong Buy with Decreased Target to $330 on, Thursday, April 23rd, 2020
  • Steven Seedhouse of "Citigroup" Downgraded from Hold to Strong Sell on, Thursday, April 23rd, 2020